Pharmacal, a company based in Wisconsin, announced the immediate withdrawal from the market of its eczema treatment cream and skin protectant, MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream. The decision was taken after Food and Drug Administration (FDA) identified contamination of the product by the bacteria *Staphylococcus aureus*. The regulatory agency warned that the use of the cream could pose serious risks to the health of consumers.

Contamination by this bacteria can result in infections that range from localized to severe or even fatal adverse events. The FDA highlighted that individuals with compromised immune systems or already fragile skin, such as people with wounds, burns or other skin conditions, are at increased risk of developing serious infections. The company, however, stated that it had not received reports of adverse events related to this recall at the time of notification.

Contaminação due to dangerous bacteria causes health alert

The discovery of the contamination was formally announced by the FDA on May 12, highlighting a crucial failure in quality control for a product that is widely used by people with sensitive dermatological conditions. *Staphylococcus aureus* is a common bacteria, but it can cause serious illness when it enters the body through open wounds or compromised skin. Para patients with eczema, who often have weakened skin barriers, the risk of infection is significantly increased, making the presence of bacteria in the cream an imminent danger.

More on this story: Croûtons Sold at Kroger Recalled for Possible Salmonella Contamination

The product in question is marketed as “hypoallergenic” and “safe for children and babies” on the Pharmacal website. Sua formulation is designed to provide fast and long-lasting relief from itching, irritation, dryness, roughness, redness and cracking. Essa’s promise of safety and relief contrasts sharply with the danger revealed by bacterial contamination. The presence of the bacteria in a cream intended for sensitive skin, including children’s, raises significant concerns about production standards.

Detalhes specific to the affected product and its distribution

The recall covers a specific batch of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream cream. Authorities and the company have provided detailed identifiers so that consumers can check if they have the contaminated product in their homes. It is essential that users verify this information to ensure security.

• Formato:Tubos 6 oz.
• Product Código:5106
• UPC:012277051067
• Lote:1024088
• Data expiration date:Novembro 2026

Este specific batch was distributed on a large scale throughout the national territory. Sales occurred through various channels, including wholesalers, retail stores and e-commerce platforms such as Amazon. Wide distribution increases the need for clear and efficient communication to reach all potentially affected consumers.

Recomendações urgent for consumers after warning

Diante of the identified risk, the FDA and Pharmacal have issued clear guidance for consumers who may have purchased MG217 cream. The regulatory agency emphasizes the importance of following instructions to avoid health complications.

Learn more: Recall of 380,000 packaging of Peter Rabbit Organics baby food due to plastic risk in the US

The main recommendation is that consumers immediately stop using the product. Após interruption of use, the cream must be disposed of safely, avoiding any further contact. Pharmacal has already started the notification process to its distributors, sending letters by email and organizing the return of all recalled products.

Para questions or additional information, Pharmacal has provided a contact channel. Consumers can call 800-558-6614 or email aimho@pharmacalway.com. Service is available Monday through Friday, from 8 a.m. to 5 p.m. central time.

Impactos of Staphylococcus aureus in human health

*Staphylococcus aureus* is a gram-positive bacteria that can normally reside on the skin and nostrils of around 30% of people without causing problems. Contudo, when the skin has breaks in its protective barrier, such as open wounds, cuts or inflammation caused by eczema, bacteria can penetrate the body and trigger a series of infections. Estas infections vary in severity, from superficial conditions to more serious conditions.

Entre the least severe conditions, *Staphylococcus aureus* can cause folliculitis, boils and cellulitis. In more serious cases, especially in individuals with compromised immunity, the bacteria can reach the bloodstream, causing bacteremia, sepsis, endocarditis or pneumonia. The bacteria’s ability to develop resistance to antibiotics, as in the case of *MRSA* (methicillin-resistant Staphylococcus aureus), makes the treatment of these infections even more complex and dangerous. Therefore, contamination of a topical product, such as a skin cream, represents a serious threat to public health, requiring immediate action from health authorities.